{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.572","meta":{"versionId":"5","lastUpdated":"2019-03-02T01:00:10.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.572","version":"20190302","name":"Estrogen and Progesterone Receptor Negative Breast Cancer","status":"active","date":"2019-03-02T01:00:10-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","version":"2021","concept":[{"code":"3316F","display":"Estrogen receptor (ER) and progesterone receptor (PR) negative breast cancer (ONC)"}]}]},"expansion":{"identifier":"urn:uuid:2d25157e-2214-490b-be9c-0ca75b04010d","timestamp":"2022-06-10T07:29:07-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"3316F","display":"Estrogen receptor (ER) and progesterone receptor (PR) negative breast cancer (ONC)"}]}}